LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending2018-08-312017-08-312016-08-312015-08-31
Net Income-6,598.843-1,869.277-1,214.773-1,770.5
Operating Activities, Cash Flows Provided By or Used In
Depreciation2.3071.4880.6190.619
Adjustments To Net Income4,449.789623.002215.331315.201
Changes In Accounts Receivables-245.458-7.71-6.20165.62
Changes In Liabilities-13.873-35.85369.437-60.48
Changes In Inventories-33.025-1.061-10.778-167.985
Changes In Other Operating Activities-78.876-256.498285.509117.117
Total Cash Flow From Operating Activities-2,517.979-1,545.909-660.856-1,501.027
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures---3.094-3.094
Investments----
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-155.399-9.699-20.102684.817
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings--5095-98.742
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities1,867.2243,995.536514.292373.255
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-806.1532,439.928-166.666-442.955